Lindsay Scheetz
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Immunotherapy and Immune Responses 7
- Immune Response and Inflammation 2
- Oncology 6
- Cancer Immunotherapy and Biomarkers 4
- CAR-T cell therapy research 2
- Co-authors
- James J. Moon (8 shared papers)Anna Schwendeman (7 shared papers)María G. Castro (4 shared papers)Pedro R. Löwenstein (3 shared papers)Qiao Li (1 shared paper)Yao Xu (4 shared papers)Kyong Soo Park (1 shared paper)Alireza Hassani Najafabadi (4 shared papers)
- Journals
- Nano Letters (2 papers)Nature Biomedical Engineering (1 paper)Clinical Cancer Research (1 paper)Advanced Therapeutics (1 paper)International Journal of Molecular Sciences (1 paper)
- Partner nations
- United StatesChinaGermany
In The Last Decade
Lindsay Scheetz
9 papers receiving 574 citations
Peers
Comparison fields: 5 of 62
- Immunology 326
- Biomaterials 123
- Oncology 172
- Drug Discovery 1
- Biomedical Engineering 221
Countries citing papers authored by Lindsay Scheetz
This map shows the geographic impact of Lindsay Scheetz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lindsay Scheetz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lindsay Scheetz more than expected).
Fields of papers citing papers by Lindsay Scheetz
This network shows the impact of papers produced by Lindsay Scheetz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lindsay Scheetz. The network helps show where Lindsay Scheetz may publish in the future.
Co-authors
The 25 scholars most cited alongside Lindsay Scheetz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 166 | |
| 2 | 2018 | 110 | |
| 3 | 2020 | 80 | |
| 4 | 2020 | 66 | |
| 5 | 2020 | 64 | |
| 6 | 2020 | 29 | |
| 7 | 2018 | 26 | |
| 8 | 2020 | 19 | |
| 9 | 2020 | 17 |
About Lindsay Scheetz
Lindsay Scheetz is a scholar working on Immunology, Oncology, Biomaterials, Biomedical Engineering and Genetics, having authored 9 papers that have together received 577 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (7 papers), Cancer Immunotherapy and Biomarkers (4 papers), Immune Response and Inflammation (2 papers), CAR-T cell therapy research (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Characterization and Applications of Magnetic Nanoparticles (1 paper), Nanoplatforms for cancer theranostics (1 paper) and Cancer Research and Treatments (1 paper). The work is most often cited by research in Immunology (326 citations), Biomaterials (123 citations), Oncology (172 citations), Drug Discovery (1 citation) and Biomedical Engineering (221 citations). Lindsay Scheetz has collaborated with scholars based in United States, China and Germany. Frequent co-authors include James J. Moon, Anna Schwendeman, María G. Castro, Pedro R. Löwenstein, Qiao Li, Yao Xu, Kyong Soo Park, Alireza Hassani Najafabadi, Lukasz J. Ochyl and Xiaoqi Sun. Their work appears in journals such as Nano Letters, Nature Biomedical Engineering, Clinical Cancer Research, Advanced Therapeutics and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.